Quotes are at least 15-min delayed:2026/11/05 08:07 EST
Pre Market
|
||||
|
178.7 
|
|
|
Regular Hours (Closed)
|
|
|
|
|
||||||||||||
|
|
|
|
|
178.2
|
|
|
| Valuation Estimation |
|
EPS (Current/Estimated)
-0.21/2.74
|
|
Enterprise Value
11.99B
|
| Balance Sheet |
|
Book Value Per Share
32.95
|
| Cash Flow |
|
Cash Flow Yield
0.01
|
| Income Statement |
|
Total Revenue
638.76M
|
|
Operating Revenue Per Share
10.55
|
|
Industry Comparison
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
|
Business Description
|
|||
| Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%,and 19% of revenue, respectively. |
